US 10117915
Modulation of yeast-based immunotherapy products and responses
granted A61KA61K2039/505A61K2039/523
Quick answer
US patent 10117915 (Modulation of yeast-based immunotherapy products and responses) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/523, A61K2039/57, A61K36/06